Scopi is bringing smaller, smarter endoscopy to primary care. Nasal congestion is the cause of 63 million medical visits every year. It is the #1 cause of ineffective antibiotic prescriptions and a $32 billion healthcare burden. Our hardware endoscopy platform and suite of AI diagnostic algorithms enable primary care practitioners to work remotely with specialists to diagnose sinonasal conditions like rhinosinusitis. This earlier diagnosis improves clinical outcomes and reduces costs. Based on research spun out of Stanford University, Scopi is a mission-based company focused on improving access to healthcare by providing high quality affordable diagnostic tools to practitioners.